InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Malik Rajesh, Directeur Médical. Director active across 2 companies, notably G1 Therapeutics, Inc.. Aggregated, 20 reports have been recorded. Breakdown: 1 buy · 4 sells. Total volume traded: €72k. Activity tracked since 10 May 2021. The latest transaction was filed on 5 July 2024 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations20 total
17,900 sharesCommon StockSEC:0000950170-24-107800:0
2,475 shares@ US$2.50776.7% of flowCommon StockSEC:0001562180-24-005658:0
8,151 shares@ US$4.788842.4% of flowCommon StockSEC:0001562180-24-004058:0
28,600 shares@ US$0.309.3% of flowCommon StockSEC:0001562180-24-001296:0
37,300 shares0Common StockSEC:0001562180-24-000326:0
3,700 sharesCommon StockSEC:0001104659-23-129770:0
21,439 shares@ US$0.399.1% of flowCommon StockSEC:0001562180-23-008346:0
1,361 shares@ US$2.45373.6% of flowCommon StockSEC:0001562180-23-005813:0
35,000 shares0Common StockSEC:0001562180-23-004097:0
17,900 shares0Common StockSEC:0001562180-23-000252:0
14,000 shares@ US$0.304.6% of flowCommon StockSEC:0001562180-22-008338:0
3,700 shares@ US$6.66100.0% of flowCommon StockSEC:0001104659-22-122390:0
Ideal exit: 25 Aug 2023 (T+270)
18,000 shares@ US$0.398.3% of flowCommon StockSEC:0001562180-22-006701:0
648 shares@ US$5.17153.8% of flowCommon StockSEC:0001562180-22-005555:0
10,000 shares@ US$0.3051.9% of flowCommon StockSEC:0001562180-22-000955
10,000 shares@ US$0.3026.0% of flowCommon StockSEC:0001562180-22-000955:0
12,000 shares0Common StockSEC:0001562180-22-000305
12,000 shares0Common StockSEC:0001562180-22-000305:0
10,000 shares@ US$0.3024.0% of flowCommon StockSEC:0001562180-21-003395
10,000 shares@ US$0.3024.0% of flowCommon StockSEC:0001562180-21-003395:0
20 of 20 declarations
About Malik Rajesh
Rajesh Malik is the Chief Medical Officer at G1 Therapeutics, Inc. He oversees the company's medical and clinical initiatives, ensuring compliance and effectiveness.
